REGULATIONS GOVERNING CLINICAL TRIALS IN INDIA, EUROPE AND USA- A COMPARATIVE STUDY
Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. These studies also may show which medical approaches work best for certain illnesses or groups of people. The purpose of clinical trials is research, so the studies follow strict scientific standards. These standards protect patients and help produce reliable study results. Clinical trials are one of the final stages of a long and careful research process. The process often begins in a laboratory (lab), where scientists first develop and test new ideas. If an approach seems promising, the next step may involve animal testing. This shows how the approach affects a living body and whether it is harmful. However, an approach that works well in the lab or animals does not always work well in people. Thus, research in humans is needed.
2. Clinical Trials [Internet]. PubMed Health [Cited 2017 Jan 12]. Available from:
3. F. Hoffmann-La Roche Ltd GPS Public Affairs. Understanding clinical trials [Internet]. Basel, Switzerland. [Cited 2017 Feb 11]. Available from:
4. Tharani R. An Introduction to Clinical Trial Regulatory Agencies in India [Internet]. [Cited 2017 Feb 12]. Available from:
5. European Medicines Agency – Science Medicines Health. [Internet]. [Cited 2017 Feb 04]. Available from:
6. European Commission - Medicinal Products for Human Use. [Internet]. [Cited 2017 Feb 16]. Available from:
7. Sherwood, Ted. "Generic Drugs: Overview of ANDA Review Process" [Internet]. CDER Forum for International Drug Regulatory Authorities. [Cited 2017 Feb 08]. Available from:
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM